Latest Partnerships News

Page 19 of 746
NTAW Holdings improved margins, reduced inventory and cut gross debt in FY2026, but remained loss-making as revenue fell sharply after the loss of key distribution rights. Management is targeting modest growth in FY2027 while covenant obligations and cash generation remain central tests.
Victor Sage
Victor Sage
9 Oct 2026
New Zealand Rural Land Company’s 75%-owned partnership has conditionally agreed to sell five Hawke’s Bay orchards for $18.84 million, as uncertainty from the Kiwi Crunch administration continues to cloud FY26 earnings. Completion depends on Overseas Investment Office consent.
Ada Torres
Ada Torres
9 Oct 2026
Emyria’s FY26 annual report shows a rapidly expanding psychedelic-assisted care network, with revenue up 210% and treatment capacity reaching 18 beds across four states. The gains came alongside a larger loss, $4.6 million in operating cash outflow and an auditor-highlighted material uncertainty over the company’s ability to continue without further funding.
Victor Sage
Victor Sage
9 Oct 2026
City Chic Collective lifted FY26 underlying EBITDA 92% to $12.3 million despite a 3.1% revenue decline, helped by stronger ANZ trading, higher margins and a leaner cost base. The retailer remains loss-making after tax, but enters FY27 with $5.2 million in net cash and early signs of renewed store momentum.
Victor Sage
Victor Sage
9 Oct 2026
SRJ Technologies has moved its Dubai Petroleum relationship from proof of concept into revenue-generating field operations, with an indicative opportunity pipeline of up to US$4.4 million. Angola mobilisation and an expanded emissions programme add near-term activity, although several opportunities remain uncommitted.
Victor Sage
Victor Sage
8 Oct 2026
Renascor has produced battery-grade purified spherical graphite at demonstration scale, achieving 99.97% carbon purity through its hydrofluoric acid-free process. The result strengthens the commercialisation case, but Siviour graphite trials, customer qualification and project financing are still ahead.
Victor Sage
Victor Sage
7 Oct 2026
ECS Botanics is taking six Australian-grown medicinal cannabis flower products into the UK through Curaleaf Laboratories, with initial supply targeted for November. The two-year deal offers access to UK sell-through but no guaranteed volumes, revenue or minimum purchases.
Victor Sage
Victor Sage
7 Oct 2026
PhosCo has paired a non-binding development partnership with a proposed $1.4 million investment from Tunisia’s STUDI International, giving the Gasaat project a local engineering partner as feasibility work approaches. The funding and collaboration remain subject to formal documentation, leaving execution as the next test.
Maxwell Dee
Maxwell Dee
7 Oct 2026
Tower has lifted its FY26 underlying NPAT guidance to $69 million-$79 million after large event claims came in below the allowance built into its forecast. Customer growth also remained strong, although customer remediation costs will continue to weigh on reported profit.
Victor Sage
Victor Sage
6 Oct 2026
Optiscan Imaging has lodged a US FDA 510(k) application for InVue, its precision surgery device designed to provide cellular-level imaging during operations. The submission moves the technology into formal regulatory review, but clearance and commercialisation remain uncertain.
Victor Sage
Victor Sage
5 Oct 2026
Radiopharm says the FDA has provided a clear framework for the pivotal development of RAD101, its investigational brain metastases imaging agent. The company is preparing for Phase 3 while awaiting formal meeting minutes that could still refine the trial design and regulatory requirements.
Victor Sage
Victor Sage
5 Oct 2026
Aurora Labs has appointed Andrew Garth as chief executive, moving former CEO Rebekah Letheby into a newly focused chief operating role. The reshuffle is intended to separate commercial strategy from technical execution as the company pursues scaled manufacturing and defence opportunities.
Victor Sage
Victor Sage
5 Oct 2026

Browse the archive

Full archive